Catalog number: 544 - MBS131292-100mg
Product Category: Business & Industrial > Science & Laboratory
Size: 100mg
206423
CSC-C0461
Breast Carcinoma Cells
B6171-10
IC50: 16 nMCC-223 is an orally bioavailable mTOR inhibitor.The mammalian target of rapamycin (mTOR) pathway is critical for tumor development, and mTOR inhibitors have revealed modest results.
H-8290.1000
Sum Formula: C158H219N37O44; CAS# [130915-89-8]
MBS8246659-10mg
MBS8246659-1mg